Article
Personalized radiomics signature to screen for KIT-11 mutation genotypes among patients with gastrointestinal stromal tumors: a retrospective multicenter study.
Journal of translational medicine - 16 Oct 2023
Zhang Qing-Wei, Zhang Ran-Ying, Yan Zhi-Bo, Zhao Yu-Xuan, Wang Xin-Yuan, Jin Jing-Zheng, Qiu Qi-Xuan, Chen Jie-Jun, Xie Zhen-Hui, Lin Jiang, Cao Hui, Zhou Yan, Chen Hui-Min, Li Xiao-Bo
Abstract excerpt
OBJECTIVES: Gastrointestinal stromal tumors (GISTs) carrying different KIT exon 11 (KIT-11) mutations exhibit varying prognoses and responses to Imatinib. Herein, we aimed to determine whether computed tomography (CT) radiomics can accurately stratify KIT-11 mutation genotypes to benefit Imatinib therapy and GISTs monitoring. METHODS: Overall, 1143 GISTs from 3 independent centers were separated into a training...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
